Volume 11, Issue 2, Pages (August 1999)

Slides:



Advertisements
Similar presentations
Volume 19, Issue 3, Pages (September 2003)
Advertisements

Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Volume 42, Issue 3, Pages (March 2015)
Volume 79, Issue 9, Pages (May 2011)
HongMei Li, MeiFang Dai, Yuan Zhuang  Immunity 
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 25, Issue 6, Pages e6 (June 2017)
Volume 18, Issue 5, Pages (May 2003)
Volume 38, Issue 3, Pages (March 2013)
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
Volume 132, Issue 7, Pages (June 2007)
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
Lack of antigen-specific tissue remodeling in mice deficient in the macrophage galactose-type calcium-type lectin 1/CD301a by Kayoko Sato, Yasuyuki Imai,
Volume 37, Issue 6, Pages (December 2012)
Volume 126, Issue 7, Pages (June 2004)
Volume 29, Issue 6, Pages (December 2008)
Volume 72, Issue 7, Pages (October 2007)
Volume 18, Issue 4, Pages (April 2003)
Volume 18, Issue 5, Pages (May 2003)
Volume 18, Issue 2, Pages (February 2003)
Volume 28, Issue 2, Pages (February 2008)
Ananda W Goldrath, Michael J Bevan  Immunity 
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells  Aixin Yu, Linjian Zhu, Norman H. Altman,
HongMei Li, MeiFang Dai, Yuan Zhuang  Immunity 
Volume 82, Issue 9, Pages (November 2012)
Volume 16, Issue 4, Pages (April 2002)
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4+ T Cells  Cynthia A Chambers, Timothy J Sullivan,
Volume 19, Issue 3, Pages (September 2003)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
CD22 is a negative regulator of B-cell receptor signalling
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
Volume 135, Issue 4, Pages (October 2008)
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
Volume 13, Issue 6, Pages (December 2000)
Volume 9, Issue 5, Pages (November 1998)
Volume 25, Issue 5, Pages (November 2006)
Volume 14, Issue 5, Pages (May 2001)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Volume 65, Issue 5, Pages (May 2004)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
The Fas antigen is involved in thymic T-cell development as a costimulatory molecule, but not in the deletion of neglected thymocytes  Kazuhiro Kurasawa,
Volume 15, Issue 5, Pages (November 2001)
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
A Critical Role for Complement in Maintenance of Self-Tolerance
Volume 23, Issue 3, Pages (April 2018)
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 75, Issue 5, Pages (March 2009)
Volume 17, Issue 5, Pages (November 2002)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Repeated Topical Challenge with Chemical Antigen Elicits Sustained Dermatitis in NC/Nga Mice in Specific-Pathogen-Free Condition  Yoshiaki Tomimori, Yoshitaka.
Volume 17, Issue 4, Pages (October 2002)
Volume 7, Issue 2, Pages (August 1997)
A Function of Fas-Associated Death Domain Protein in Cell Cycle Progression Localized to a Single Amino Acid at Its C-Terminal Region  Zi Chun Hua, Sue.
SOCS1 Prevents Potentially Skin-Reactive Cytotoxic T Lymphocytes from Gaining the Ability to Cause Inflammatory Lesions  Galaxia Maria Rodriguez, Dante.
Volume 25, Issue 1, Pages (July 2006)
Volume 25, Issue 12, Pages e5 (December 2018)
Volume 75, Issue 5, Pages (March 2009)
Volume 132, Issue 7, Pages (June 2007)
Volume 58, Issue 5, Pages (November 2000)
Volume 30, Issue 2, Pages (February 2009)
Volume 23, Issue 4, Pages (October 2005)
Volume 22, Issue 3, Pages (March 2005)
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Volume 11, Issue 2, Pages 141-151 (August 1999) Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor  Hiroyuki Nishimura, Masato Nose, Hiroshi Hiai, Nagahiro Minato, Tasuku Honjo  Immunity  Volume 11, Issue 2, Pages 141-151 (August 1999) DOI: 10.1016/S1074-7613(00)80089-8

Figure 1 Immunohistochemical Examination of Immunoglobulin Deposits in Renal Glomeruli from B6-PD-1−/− and B6-lpr/lpr × PD-1−/− Mice Sections of kidneys from B6, B6-PD-1−/−, B6-lpr/lpr, B6-lpr/lpr × PD-1−/−, and MRL-lpr/lpr mice at 24–27 weeks of age were stained with goat antisera to mouse IgM, IgG2a, IgG3, or complement C3. Representative pictures are shown. Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)

Figure 2 Histology of Various Tissues from B6-PD-1−/− and B6-lpr/lpr × PD-1−/− Mice Representative pictures of various organs from B6 (A and D) and B6-PD-1−/− mice (B, C, E, and F) at 14 months of age and B6-lpr/lpr (G, J, and M) and B6-lpr/lpr × PD-1−/− mice (H, I, K, L, N, and O) at 24–27 weeks of age are shown; (A)–(C) and (G)–(I), kidney; (D)–(F) and (J)–(L), foot joints; (M) and (N), bone marrow; and (O), lymph node. All pictures are H-E staining except that (C) and (I) are PAS staining pictures. Original magnifications are as follows: (A)–(C), (F), (G)–(I), and (L), ×100; (D), (E), (J), and (K), ×25; (M) and (N), ×50; (O), ×200. Glomeruli of B6-PD-1−/− mice at 14 months of age were enlarged and lobulated with increased cellularity associated with marked inflammatory cell infiltration with hyaline droplet deposition in mesangium and hyaline thrombi in capillary lumen (B) accompanied by deposition of PAS-positive materials along the capillary wall and in mesangium (C). Foot joints of B6-PD-1−/− mice were accompanied with proliferation of synovial lining layers, inflammatory cell infiltration, and granulomatous lesions in the sublining region (grade 2) (E), which extended into bone matrices with pannus formation accompanied by osteoclast infiltration (grade 3) (F). Similar trends mentioned above were observed in kidney (H and I) and foot joints (K and L) of B6-lpr/lpr × PD-1−/− mice at 24–27 weeks of age. Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)

Figure 3 Flow Cytometric Analysis of Lymph Node Cells from B6-lpr/lpr × PD-1−/− Mice (A) Lymph node cells from B6-lpr/lpr, B6-lpr/lpr × PD-1−/−, and MRL-lpr/lpr mice at 6 months of age were stained with anti-B220 and anti-Thy-1 or with anti-CD4 and CD8 mAbs. Numbers indicate percentages in gated regions. (B) Lymph node cells from B6-lpr/lpr mice at 16 weeks of age were examined for the expression of indicated antigens. In upper panels, the expression of CD4/CD8 or PD-1/TCRβ, CD25, CD69, or CD44 was shown in contour plots. In lower panels, the expression of PD-1 or TCRβ on CD4−CD8−, CD4+CD8−, CD4−CD8+ subsets was shown in histograms. Bold lines represent control staining. Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)

Figure 4 Histology of Various Tissues from 2C × PD-1−/− (H-2b/d) Mice at 10 Weeks of Age The representative pictures of H-E staining of skin lesions (A–C), hearts (D–F), lungs (G–I), liver (J), salivary gland (K), and pancreas (L) are shown. Sections from skin lesions were stained with anti-mouse CD8a (M and N) or anti-mouse 2C TCR (1B2) mAb (O and P). Arrows indicate DAB-positive cells in (N) and (P) panels. Pictures (A), (D), (G), (M), and (O) are from control 2C mice, and others are from 2C × PD-1−/− (H-2b/d) mice. The original magnifications are as follows: (D), (E), (G), and (H), ×10; (A), (B), (J), (K), and (L), ×25; (F), (I), and (M–P), ×50; (C), ×100. In the skin lesions of 2C × PD-1−/− (H-2b/d) mice, hyperkeratosis, hypergranulosis, and acanthosis were observed as well as the dense inflammatory cell infiltration in the dermis associated with subepidermal clefts (liquefaction degeneration) (C) and destruction of skin appendage (B) typically seen in graft-versus-host disease as compared with that of control 2C (H-2b/d) mice (A). Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)

Figure 5 Flow Cytometric Analyses of Thymocytes and Splenocytes from 2C × PD-1+/+ and 2C × PD-1−/− Mice in H-2b/d Autoreactive Condition Total thymocytes (A) and splenocytes (B) were examined for the expression of CD4 and CD8. The numbers in quadrates indicate percentages of gated regions. 2C-TCR expression was examined for CD4+ cells. (C) The expression of indicated antigens was examined in CD8 compartments gated as shown in (B). The numbers indicate percentages in gated regions of each histogram. The upper (+/+) and lower (−/−) panels denote 2C × PD-1+/+ and 2C × PD-1−/− mice, respectively. The representative data are shown. The numbers indicate percentages of gated regions. Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)

Figure 6 Proliferative Responses of 2C-TCR+CD8+ T Cells from B6-2C and 2C × PD-1−/− Mice (A) Flow cytometric analysis of 2C-TCR+ T cells expanded by coculturing with BALB/c (H-2d/d) splenocytes. 2C-TCR+ T cells from 2C × PD-1+/+ (upper panels) or 2C × PD-1−/− (lower panels) mice were analyzed for the expression of indicated antigens on the surface. (B–D) Thymidine incorporation assay. 2C+CD8+ T cells from 2C × PD-1+/+ (open rectangles) and 2C × PD-1−/− (open circles) mice were stimulated with indicated units of IL-2 (B) or concentration of anti-CD3ε (C). 2C+CD8+ T cells from 2C × PD-1+/+ (rectangles) or 2C × PD-1−/− (circles) mice were stimulated with indicated numbers of mitomycin C–treated splenocytes from B6 (open symbols) and BALB/c (closed symbols) mice (D). Bars indicate standard deviations. These experiments were performed in triplicate. Immunity 1999 11, 141-151DOI: (10.1016/S1074-7613(00)80089-8)